Improving Access to T1D Clinical Trials Webinar

Transcript

Pdf Summary

The webinar "Improving Access to T1D Clinical Trials" led by Natalie Bellini and featuring Anastasia Albanese, Ashby Walker, and Sarah Weston, focused on strategies to enhance participation in Type 1 Diabetes (T1D) clinical trials. The session highlighted the importance of clinical trials, explained their phases, and emphasized the voluntary nature of participation. <br /><br />Dr. Albanese underscored how clinical trials assess new treatments for safety and effectiveness, and detailed ongoing trials targeting insulin-producing beta cell protection, among others. Barriers discussed included low patient referral rates from physicians, many of whom are unaware of trial opportunities or lack time for engagement.<br /><br />Ashby Walker highlighted the need for diverse trial participation to ensure study findings can be generalized to broader populations. She noted that diversity is critical to identifying epigenetic and cultural factors affecting disease outcomes and stressed that historically marginalized communities are often underrepresented due to lack of invitation rather than mistrust.<br /><br />Sarah Weston addressed common roadblocks including fear of side effects and limited awareness about trials. She emphasized education on the availability and benefits of trials to reduce barriers. She also discussed strategies for patient empowerment through collaborative communication, ensuring patients' understanding, and acknowledging their potential concerns.<br /><br />The session aimed to encourage healthcare providers to actively discuss and refer patients to clinical trials, while fostering an inclusive atmosphere conducive to shared decision-making. It provided attendees with resources and strategies, including community engagement and partnerships beyond traditional endocrinology settings, to promote broader trial participation. The discussions underscored the collaborative potential in medical trials to advance T1D care and research.

Keywords

T1D clinical trials

Natalie Bellini

Anastasia Albanese

Ashby Walker

Sarah Weston

patient referral barriers

diverse participation

epigenetic factors

patient empowerment

inclusive healthcare